Bibliographic Details
| Title: |
Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: a report from the Childrens Cancer Study Group. |
| Authors: |
Feig SA; University of California School of Medicine, Los Angeles., Krailo MD, Harris RE, Baum E, Holcenberg JS, Kaizer H, Steinherz L, Pendergrass TW, Saunders EF, Warkentin PL, et. al. |
| Source: |
Medical and pediatric oncology [Med Pediatr Oncol] 1992; Vol. 20 (2), pp. 124-9. |
| Publication Type: |
Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: |
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7506654 Publication Model: Print Cited Medium: Print ISSN: 0098-1532 (Print) Linking ISSN: 00981532 NLM ISO Abbreviation: Med Pediatr Oncol Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
